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Strengths and limitations of this study
 ► There is limited research into the role of pharmacists 
in this setting; this is the first qualitative study that 
has explored the role of pharmacists as part of the 
general practice team in relation to oral healthcare.
 ► A wide range of general practice healthcare pro-
fessionals and patients participated in this study; 
however, a limitation is that no general dental prac-
titioners were interviewed.
 ► Semistructured interviews provided rich qualitative 
data and an iterative process of concurrent data 
collection and constant comparative analysis facil-
itated the simultaneous exploration, refinement and 
enrichment of key themes.
ABSTRACT
Objective To explore the attitudes towards, and 
perceptions of, primary care healthcare staff and patients, 
regarding the role of clinical pharmacists in the provision of 
oral health advice and collaboration with dentists in general 
practice.
Design Interpretivist methodology using qualitative semi- 
structured interviews and focus groups.
Participants 22 participants; 10 pharmacists; 3 general 
practitioners; 2 nurses; 1 practice manager; 6 patients.
Setting Primary care general medical practices in the North 
East of England and the University of Sunderland Patient 
Carer and Public Involvement group.
Methods One- to- one semi- structured interviews were 
performed with primary care healthcare staff. An iterative 
approach using constant comparative analysis facilitated the 
ongoing enrichment of data; salient themes were identified 
using Framework Analysis and related back to extant 
literature. A focus group was held with patients to further 
explore key themes.
Results Four salient and inter- related themes emerged: 
enhanced clinical roles; indicating rapidly changing roles 
of pharmacists working in general practice, increased 
responsibility and accountability of pharmacist prescribers 
and the delivery of advanced clinical services; limited 
knowledge; indicating basic understanding of appropriate 
oral health advice, but limited insight and provision of advice 
to patients with regards to links with systemic diseases and 
medication; geographical/situational isolation of the dental 
team; indicating the disparate contexts and challenges 
of multidisciplinary working in oral health, and patients’ 
attitudes towards dental care; integration of oral health 
advice; indicating the potential of pharmacists to integrate 
oral health advice into current roles and to target specific 
patient groups in practice.
Conclusions The lack of integration between oral and 
general healthcare services potentially impacts negatively 
on patient care, requiring further interprofessional oral health 
education. The developing role of the pharmacist in general 
practice represents an opportunity to integrate oral health 
advice and/or interventions into the management of patients 
in this setting.
InTRODuCTIOn
Oral health conditions are thought to affect a 
significant proportion of the world’s popula-
tion, approximately 3.9 billion people world-
wide and cost the National Health Service 
(NHS) in England £3.4 billion per year.1 2 
The most recent Adult Dental Health Survey 
(2009) stated that 23% of the UK popula-
tion do not attend a dentist.3 Oral health is 
important for general health and well- being, 
and there is increasing evidence that has 
linked periodontitis to a number of diseases, 
such as cardiovascular disease and diabetes.4 5
Wilson and Soni’s recent opinion piece 
in the British Dental Journal highlighted 
the potential for a collaborative approach 
between pharmacy and dentistry in the 
management of chronic diseases, such as 
diabetes and the potential capacity for phar-
macists to encourage hard- to- reach indi-
viduals to become dental attenders.6 In the 
UK, dental treatment is available privately or 
provided as part of the NHS. However, even 
under NHS arrangements, the majority of 
patients pay a contribution towards the cost of 
 o
n
 February 29, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032261 on 28 February 2020. Downloaded from 
2 Sturrock A, et al. BMJ Open 2020;10:e032261. doi:10.1136/bmjopen-2019-032261
Open access 
their care, and currently care is charged into one of three 
bands (band 1 £22.70; band 2 £62.10; band 3 £269.30) 
depending on the extent and complexity of treatment 
that is needed.7
Approximately half of the adults in the UK are affected 
by some level of periodontitis; a chronic inflammatory 
disease caused by bacterial infection of the supporting 
tissues surrounding the teeth.3 This condition is usually 
painless and often goes unnoticed and untreated until it 
reaches an advanced stage.8 The Cochrane Collaboration 
published a review in 2015, highlighting that randomised 
controlled trials have demonstrated that periodontal 
therapy is associated with a 3–4 mmol/mol (0.3%–0.4%) 
reduction in HbA1c levels after 3 months9; this is a clin-
ical impact equivalent to adding a second drug to a phar-
macological regimen.10 There is evidence that even a 
modest reduction in HbA1c is associated with improving 
outcomes for patients with type 2 diabetes; a 1% reduc-
tion in HbA1c has been associated with a 21% reduction 
in diabetes- related death, 14% reduction in myocardial 
infarctions and 37% reduction in microvascular compli-
cations.11 There is clear evidence of a bidirectional rela-
tionship between periodontitis and diabetes; poorly 
controlled diabetes increases the risk of periodontitis 2–3 
times, and in turn periodontitis is associated with higher 
HbA1c levels and worse diabetes complications.12 13 There 
is also evidence of an association between atherosclerotic 
cardiovascular disease and poor oral health.14
A number of medications can negatively impact oral 
health, representing a significant opportunity for phar-
macists to provide advice in relation to the prevention 
and management of these issues. For example, polyphar-
macy and a high anticholinergic burden are associated 
with the development of xerostomia and inhaled corti-
costeroids with oropharyngeal adverse events, such as 
oral candidiasis.15 16 Calcium channel blockers such as 
nifedipine, ciclosporin and phenytoin are all associated 
with development of drug- induced gingival overgrowth.17 
Medication- related osteonecrosis of the jaw (MRONJ) 
is a rare, yet significant complication of antiresorptive 
and antiangiogenic drugs used in the treatment of oste-
oporosis and cancer.18 MRONJ is difficult to treat and 
significantly impacts on patient’s quality of life19; there-
fore a multidisciplinary approach to prevention is usually 
recommended.18
Evidence suggests that pharmacists working in a 
community pharmacy setting see the provision of oral 
health promotion to be part of their professional role. 
An oral health promotion intervention in the North 
East of England demonstrated patient’s acceptance to 
the pharmacist’s intervention and a positive intention to 
change oral health habits.20 To the authors’ knowledge, 
no studies have explored the utilisation of pharmacists 
working in general practice to provide patients with oral 
health advice; however, a systematic review of pharmacists 
working in general practice found favourable results in 
various areas of chronic disease management and the 
optimal use of medicines.21
Following a successful pilot, NHS England’s General 
Practice Forward view (2016) committed to the invest-
ment of £112 million to further develop this role with the 
aim of providing an additional 1,500 clinical pharmacists 
to the general practice workforce by 2020.22 The Primary 
Care Pharmacy Association’s Clinical Pharmacist in 
General Practice Job Description sets out the duties and 
areas of responsibility for pharmacists in this setting in 
the UK23; this includes managing long- term conditions, 
performing medication reviews, implementing medica-
tion safety guidance, supporting public health campaigns 
and signposting to appropriate healthcare professionals.
Each of these areas represents an opportunity for the 
provision of oral healthcare by clinical pharmacists. 
Potential oral health- related roles could include the 
provision of oral hygiene advice and the recommenda-
tion of appropriate products, which could be targeted to 
high risk patient groups or those in which the benefits of 
improved oral hygiene can impact on systemic health, for 
example, diabetes. Pharmacists could play an important 
role in the prevention or management of the oral health- 
related adverse drug effects outlined above; this includes 
the prevention of MRONJ through signposting and 
formal dental referrals, the prescribing of saliva substi-
tutes or high fluoride toothpastes, deprescribing medica-
tions implicated with xerostomia and screening patients 
for oral cancer. The role of clinical pharmacists in the 
provision of oral health advice and collaboration with 
dentists in general practice is explored in our study.
Aims
1. To explore the attitudes towards and perceptions of 
primary care healthcare staff and patients, regarding 
the role of the clinical pharmacist in providing oral 
health advice in a general practice setting.
2. To explore any potential barriers and/or facilitators in 
using pharmacists in general practice to improve the 
interprofessional management of oral health.
MeThOD
Design
An interpretive approach was adopted throughout this 
research; an initial topic guide (online supplementary 
file 1) was produced serving as a benchmark for semi- 
structured one- to- one interviews with healthcare profes-
sionals, which were audio recorded and transcribed 
verbatim. Constant comparative analysis, facilitated the 
concurrent and iterative process of data collection and 
analysis.24 This process provided the opportunity for the 
further exploration of emergent themes through subse-
quent data collection. Ritchie and Spencer’s Framework 
Analysis facilitated the process of constant comparative 
analysis and provided a systematic approach to the iden-
tification and analysis of salient themes.25 Framework 
Analysis involved a five- stage process1: familiarisation 
with the data—achieved via iterative cycles of listening to 
and rereading of transcripts2; development of a thematic 
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Table 1 Healthcare professional participant characteristics
Participant Identifier Role Years’ experience (N) Gender
1 Ph1 Pharmacist 5–9 Female
2 Ph2 Pharmacist 10–14 Male
3 Ph3 Pharmacist <5 Female
4 Ph4 Pharmacist >20 Female
5 Ph5 Pharmacist 10–14 Female
6 Ph6 Pharmacist 5–9 Male
7 Ph7 Pharmacist 10–14 Female
8 Ph8 Pharmacist 10–14 Male
9 Ph9 Pharmacist <5 Female
10 Ph10 Pharmacist 15–19 Female
11 PM1 Practice manager >20 Female
12 GP1 General practitioner 15–19 Female
13 GP2 General practitioner <5 Male
14 GP3 General practitioner >20 Male
15 N1 Nurse 15–19 Female
16 N2 Nurse >20 Female
framework—the initial themes formed the basis of a 
thematic framework3; indexing data—data were indexed 
against the thematic framework4; charting—charts were 
produced of the data within the framework5; mapping of 
the data—themes were reviewed until definitive concepts 
were produced. A focus group was held with patients to 
explore key themes; a topic guide (online supplementary 
file 2) was produced following the collection and analysis 
of data from healthcare professionals.
Participants
General practice healthcare professionals were recruited 
from 12 practices across the North East of England. Four 
distinct professional groups were recruited to the study: 
(1) pharmacists working in general practice; (2) general 
practitioners; (3) general practice administrative staff; 
(4) general practice nurses.
An invitation letter (online supplementary file 3) and 
participant information sheet (online supplementary 
file 4) were posted to medical practices in the region; an 
initial convenience sample of participants who responded 
to the invitation was implemented with further recruit-
ment facilitated via snowball sampling.
Patient participants were recruited from the Univer-
sity of Sunderland Patient Carer and Public Involve-
ment (PCPI) group; participant information sheets were 
emailed to PCPI representatives and those that responded 
to the invitation participated in a focus group.
Analysis
Constant comparative analysis facilitated the identifica-
tion and further exploration of salient themes through 
an iterative process of data collection and analysis. 
Ritchie and Spencer’s Framework Analysis (2002),25 
provided a systematic five- stage approach to data 
analysis; familiarisation with the data; development of 
a thematic framework; indexing data; charting of the 
data and mapping of the data. Themes were reviewed 
by the research team until definitive concepts could be 
produced from the data.
Patient involvement
The principal investigator met with a patient represen-
tative from the University of Sunderland PCPI group to 
discuss the initial design and ethical implications of the 
study. Following the collection and analysis of data from 
healthcare professionals, a focus group was held with 
six patients; the focus group facilitated the refinement 
of emerging concepts and the coconstruction of overar-
ching themes.
ReSulTS
22 participants were recruited to this study (tables 1 
and 2). In- depth semistructured interviews were carried 
out between October 2018 and April 2019 until no new 
themes emerged and extant ones were exhausted. Inter-
views took place at participants’ places of work or at the 
University of Sunderland, with two interviews performed 
via telephone for logistical reasons; 1 hour was designated 
for each interview. Six patients participated in a focus 
group, lasting 1 hour, held in April 2019 at the University 
of Sunderland.
Four salient inter- related themes emerged from the 
data and a coding tree was produced (online supplemen-
tary file 5): (1) enhanced clinical roles; (2) limited knowl-
edge; (3) geographical/situational isolation of the dental 
team; (4) integration of oral health advice.
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Table 2 Patient participant characteristics
Participant Identifier Role Age (years) Gender
1 Pt1 Patient 50–59 Female
2 Pt2 Patient 60–69 Male
3 Pt3 Patient 50–59 Female
4 Pt4 Patient 60–69 Male
5 Pt5 Patient 40–49 Female
6 Pt6 Patient 60–69 Female
enhanced clinical roles
Participants highlighted the accessibility of pharmacists 
as part of the general practice team, providing a comple-
mentary skill set to existing staff that enhances the provi-
sion of services provided at practices.
I’m directly contactable face- to- face by prescribers, 
GPs, nurse practitioners, nurses, admin team, every-
thing. They can just come directly into my office and 
ask me for information. So, I’m probably more like-
ly to be utilised clinically. In community pharmacy, 
you obviously have other responsibilities as well and 
the pharmacist also takes on the role of the manager. 
(Ph1)
Participants identified that general practice is a rapidly 
evolving role for pharmacists, who are increasingly 
involved with, and leading, more advanced, patient facing 
clinical services. These services require an enhanced level 
of clinical knowledge compared with more traditional 
pharmacy roles, with pharmacists increasingly inputting 
more into the clinical management of patients in this 
setting.
Our roles in the surgeries are evolving and perhaps 
new to some, but I found it on the whole to be very 
very positive and that the other staff have been ac-
cepting. (Ph8)
Many of the pharmacist participants described 
providing a higher level of clinical service facilitated 
through obtaining postgraduate prescribing qualifica-
tions resulting in a greater degree of clinical responsi-
bility and accountability.
I’m in quite an advanced clinical role now. So I do a 
lot of diagnostics and treating myself. I’m a prolific 
prescriber. (Ph7)
Participants perceived the management of chronic 
long- term conditions, with a specific focus on optimising 
therapy and the provision of detailed, clinically focused 
medication reviews to be a key role for pharmacists in this 
setting.
I would see patients for medication reviews, particu-
larly the complex ones, the ones with polypharmacy 
in particular come to me. It would be about making 
sure they are on the right regimens, making sure they 
haven’t got any adverse effects and maybe stopping 
drugs if no longer appropriate. (Ph4)
The management of high- risk medications and the 
reconciliation of medication provided on discharge or 
from a specialist setting was seen as an important part of 
the pharmacist’s role. The services provided are integrated 
into the existing practice infrastructure and the access of 
pharmacists in this setting to full clinical records facili-
tates a higher degree of clinical input. Through working 
in this setting pharmacists can also clearly communicate 
with the rest of the practice team; this includes following 
up on monitoring requirements, liaising with community 
pharmacies and updating medical records to accurately 
reflect patient’s current medication.
Some of my work is quite administrative, so dealing 
with queries, issues from community pharmacies, dis-
charge prescriptions or hospital letters, things like 
that. Making sure that patient’s medication lists are 
correct, particularly with medicines started on dis-
charge or in outpatients, you know, ones with shared 
care agreements or high- risk drugs. (Ph3)
The provision of lifestyle and preventive advice was 
seen as a key role for pharmacists, complementing work 
done by practice nurses; this would typically include sign-
posting patients and formal interprofessional referral 
where required.
There is an increasing amount of work for GPs, and 
I think the lifestyle issues seem to get shifted down 
the line as to what we are able to focus on, it’s often 
not what the patient presents with. I think both phar-
macists and nurses are good at doing that, it is about 
prioritising in that short time you have. (GP1)
Some of the patients had experience of having appoint-
ments with pharmacists in general practice. Those who 
had reported favourable experiences were positive 
towards the benefits for their care; with a particular focus 
on reviewing medications and reducing the known side- 
effects of prescribed medicines.
She (pharmacist) rang up to discuss the medication 
because they were changing my insulin. So, she was 
on about ten minutes going through everything that 
I was on to make sure I was happy, everything was bal-
anced, no side- effects and she decided to change a 
couple of things that I’d been on for a number of 
years. She was really helpful and it’s definitely better 
now. (Pt1)
Some patients had not experienced services provided 
by pharmacists in this role; a number of participants 
perceived that the benefit of pharmacists resulted from 
the accessible locations and opening hours of community 
pharmacies and were concerned that the pharmacist in 
general practice would become another healthcare profes-
sional with whom making appointments was challenging. 
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This was a common experience of patients when trying to 
make appointments with general practice staff.
You could get a doctor’s appointment more easi-
ly when we were young. But I think people tend to 
just to pop in a pharmacy, I think there’s more in-
formation in the pharmacy now, there is no wait for 
appointments and they are open all the time. (Pt3)
If you have to wait to get an appointment with the 
pharmacist at the doctor’s surgery, you may as well 
just see the doctor or whatever else, the point of a 
pharmacist to me is that it’s, like, around the corner 
and it’s easy. (Pt6)
limited knowledge
All healthcare professional participants reported limited 
knowledge of basic oral health advice and would try to 
signpost patients to dental services where possible, but 
perceived that they were able to manage common condi-
tions, such as a mouth ulcer, and provide basic oral 
hygiene advice.
You will get people presenting to surgery with queries 
around the mouth generally. Perhaps unexplained 
problems. It might be anything from halitosis, to 
soreness, to ulcers, to even presenting with dental ab-
scess because they’d rather come to us than go to a 
dentist. We try to signpost them to a dentist, but we 
can deal with some of the minor issues. (N1)
The primary care staff participants described the 
presentation of patients in general practice with dental 
problems, such as dental pain and likely infections. 
Participants described limited knowledge in the assess-
ment and management of dental infections; GPs would 
typically signpost these patients to a dentist, but did 
report a perceived duty of care to help this patient group 
if the patient was unable/unwilling to attend a dental 
appointment.
Even if a GP thinks, ‘actually, I think it’s an abscess’ 
he or she’s got a duty of care to treat that infection 
and not to leave it, even if we don’t know a great deal 
about more complex dental issues. Especially when 
they say they don’t have a dentist. (Ph10)
Participants had limited knowledge of the links 
between oral and systemic health; with oral health advice 
not usually forming part of discussions with patients in 
high risk groups, such as those with diabetes and with 
multidisciplinary diabetes teams not including dental 
professionals.
I haven’t really heard of links between the two. I see 
lots of patients with diabetes and it is definitely not 
something that I would tell patients about. (Ph5)
Although not a direct focus of interventions, pharma-
cists described a key role in the deprescribing of medi-
cations in patients with a high anticholinergic burden. 
These patients would typically have symptoms of a dry 
mouth and this would be used by some as an incentive to 
stop or reduce implicated medicines.
I look to stop some medicines during medication or 
falls reviews, medicines that have antimuscarinic side- 
effects, so like those for urinary incontinence or tri-
cyclic antidepressants that cause, like a drying effect, 
and patients experience dry mouth. (Ph1)
The pharmacists were aware of MRONJ, mainly due to 
historic Medicines and Healthcare products Regulatory 
Agency safety alerts. The actioning of these alerts was 
described as a key role of the practice pharmacist; partic-
ipants reported that following safety alerts patients were 
identified and provided signposting advice, however, 
pharmacist and GP participants acknowledged that 
these alerts are often forgotten or lose focus and need to 
become longer term initiatives, not isolated alerts.
I remember a couple of years ago, there was an alert 
and where we set it up so that all new patients going 
on a bisphosphonate got told to have a dental check- 
up before they went on. Now, I don’t know—I haven’t 
seen anything around that lately and I’ve got a feeling 
that might have lapsed a bit. Or at least I’m not aware 
of it happening. (Ph4)
The patient participants identified that their knowl-
edge in relation to oral health had almost exclusively 
come from their dentist or their parents as a child. None 
of the participants described receiving any oral health 
advice from other healthcare professionals.
I think it would be from my mum and dad and then 
the dentist. I don’t think anyone else has ever talked 
about oral health with me, maybe the school nurse a 
long time ago. (Pt5)
All participants described a need and willingness to 
receive further education and training on oral health; this 
was perceived as a deficit in both undergraduate training 
in post- registration continuing professional development.
I think it would be useful to have more training—di-
rected at general practice. I think most of us know the 
basics, but not really much depth, especially around 
how oral health and just general health and wellbe-
ing are related. (Ph3)
Geographical/situational isolation of the dental team
General practice staff reported limited collaboration with 
dental colleagues in primary care, with no formal referral 
pathways between medical and dental services and a lack 
of communication between the professional groups. 
These were all seen as significant barriers to providing 
high quality and safe oral healthcare to patients.
I would say there is anonymity really. If you compare 
it with, for example, local opticians where we have 
frequent interactions, albeit by paper, we don’t really 
 o
n
 February 29, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032261 on 28 February 2020. Downloaded from 
6 Sturrock A, et al. BMJ Open 2020;10:e032261. doi:10.1136/bmjopen-2019-032261
Open access 
get any, sort of, direct contact. Not that I can recall. 
(GP3)
We don’t seem to engage with dentists. In fact, the 
only time that I ever had a proper conversation with 
a dentist was when I worked in community pharma-
cy and that would have been over an incorrect pre-
scription or an out of stock item. And I just think, 
you know, there is a lot of cross- conversations that we 
could have. (Ph10)
There were concerns about the lack of information 
shared between primary medical and dental services and 
the impact that this has on patient safety; with dentists 
not having access to patient’s Summary Care Records 
(SCRs) and general practice staff not receiving informa-
tion about the care or interventions provided in a dental 
setting. This included a lack of information on medica-
tion prescribed by dentists.
We would never know if the dentists had prescribed 
any antibiotics or anything for a patient. Yet, if any-
one else in the primary healthcare team prescribes 
anything for our patients, we know. We would get ei-
ther a letter or a fax summary, something sent over to 
say this is what’s happened in this patient. (Ph7)
Both patients and the healthcare professionals 
described their own and their patient’s reluctance to 
engage fully with dental services; barriers include the 
cost of both preventive and remedial dental work, dental 
phobias and a lack of education on the benefits of good 
oral health.
The area I am in is very deprived and actually, I would 
say that the majority don’t ever visit the dentist, I 
think they just don’t see it as important and loads of 
them just don’t have the money, and fear, loads of 
people hate seeing a dentist unless it’s absolutely nec-
essary. (Ph5)
The patients also reported a perceived segregation 
between the dental and medical professions, with historic 
stereotyping contributing to their formative under-
standing of each role. This was described as a barrier in 
engaging with oral healthcare outside of a dental setting, 
as historically this is not an environment that patients 
associate with dental care provision.
I think it’s just the way society has brought us up in 
that the there are two defining people, dentists and 
doctors. Anything to do with dentists, you go to the 
dentist. Anything about your health you go to the doc-
tors. They have always been seen as separate. (Pt6)
Integration of oral health advice
Pharmacists working in general practice have better 
access to patient medical records than their community 
pharmacy colleagues and are therefore well placed to 
identify patients who may be suitable for targeted inter-
ventions. For example, the practice diabetes register or 
those patients prescribed medications with oral health- 
related adverse effects, such as bisphosphonates, could be 
easily identified and invited for review by the pharmacist.
In GP practices, people are coded appropriately, as 
smokers, or based on specific conditions, or you could 
look at medications that are associated with oral com-
plications and target those people. It is easy enough 
to identify potential higher risk patients. (Ph1)
Participants described the role of the pharmacist in opti-
mising medication regimens and their specific focus on 
providing input into patient care through chronic disease 
management clinics and medication reviews. All partic-
ipants agreed that the provision of appropriate lifestyle 
advice should form a key element of these consultations.
Generally, I think pharmacists can focus on medi-
cines and do a really good job getting those right, but 
with the, let’s call it, soft interventions, lifestyle advice 
etc., they seem to work better when they’re repeated 
by various people. (GP3)
Participants reported that consultations with the phar-
macist are typically less time pressured than GP appoint-
ments; with most pharmacist participants not routinely 
involved in providing acute care. This time could facili-
tate the provision of more detailed consultations, repre-
senting an opportunity to incorporate oral health advice 
into current practices.
My clinics could easily be timetabled for 20 min in-
stead of 10, and as I don’t really see acute patients or 
have the same time pressures as some of the GPs or 
practice nurses. I can talk longer and to go into more 
detail about things, there is scope to take more time 
and really reinforce the key messages. (Ph2)
I don’t see any reason why you can’t promote oral 
hygiene at a doctor’s practice, you can promote it, 
give people the information so they are properly in-
formed. Then it is up to them. (Pt2)
The incorporation of basic oral health advice can 
be integrated into the current role of the pharmacist; 
however, participants reported a need for more direction 
from professional bodies or the commissioners of local 
or national services to provide more complex interven-
tions and to improve interprofessional collaboration with 
dental professionals.
There is loads that we could do and as a practice we 
could just do it to give a better quality of care, but if 
it is a paid service or linked to certain targets etc then 
there may be more incentive to focus on it. (Ph2)
DISCuSSIOn
Our research has highlighted the disparate contexts of 
provision of oral and general healthcare in the North 
East of England. This is further hindered by a lack of 
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communication between medical and dental service 
providers, a lack of clear referral pathways and no shared 
access to medical records. All of these are significant 
barriers to the provision of high quality and safe oral 
healthcare. Further consideration and action are there-
fore needed at the level of policy and practice if patient 
safety and quality care in an oral health context are to be 
implemented and sustained in a non- dental setting.
The evolving role of the clinical pharmacist in general 
practice is facilitating the provision of additional clinical 
services and is improving patient care.21 26 The provision 
of oral healthcare by pharmacists in general practice is 
limited at present, but this role represents an opportu-
nity to target at risk patients and incorporate appropriate 
advice into current services.
The limited knowledge of oral health reported by our 
participants is similar to findings published in the litera-
ture.27 In particular, our findings in relation to the limited 
knowledge of general practice staff of the bidirectional 
relationship between periodontitis and diabetes match 
those by Bissett et al.8 Their study did not specifically 
include pharmacists and the subsequent enhancement of 
the clinical pharmacist in general practice role discussed 
in our study represents an unexplored opportunity to 
improve medical and dental collaboration.
Previous studies have identified a role for pharmacists 
working in a community pharmacy setting to provide oral 
health advice to patients.20 28–31 Our study has explored 
the expanding role of the pharmacist in the general prac-
tice setting; this has received significant funding from 
the NHS and forms a key component of NHS England’s 
General Practice Forward View (2016).21 Further explo-
ration of the potential roles of pharmacists in this setting 
is required to establish the impact made on patient care.
Further consideration needs to be made by both clini-
cians and policymakers to better integrate oral health 
into holistic healthcare provision. Research by Bissett et al 
identified that dentists tend not to contact GPs regarding 
the management of patients with diabetes, and when they 
do so, they typically communicate through the patient, 
as opposed to through formal referral channels.32 Partic-
ipants in our study reported little collaboration between 
general practice and dentists, with a lack of formal referral 
pathways and the limited sharing of patient information. 
A lack of shared information between medical and dental 
services was identified by participants in our study as a 
risk to patient safety. More than 96% of the population of 
England have a SCR that can be accessed from a variety 
of NHS service providers; however, NHS dental practices 
do not currently have access to SCRs.33 This represents a 
barrier to optimal patient care, but also potentially results 
in a risk to patient safety; dentists are currently reliant on 
patients to be able to provide accurate medication histo-
ries and general practice staff are potentially unaware 
of medication prescribed by dentists. Access to medical 
records in dental practices could improve collaboration,34 
facilitate a reduction in patient safety concerns that arise 
as a result of incomplete or inaccurate information. For 
example, accurate medication histories could reduce 
the risk of dentists and doctors inadvertently prescribing 
medication that negatively interacts with existing therapy 
or missing dentally important drugs such as bisphos-
phonates and could encourage better communication 
between settings. Participants in our study described a 
key role for pharmacists in general practice in relation to 
the reconciliation of medicines and the maintenance of 
accurate medication histories; this represents an oppor-
tunity to ensure the flow of correct information between 
care settings and could be utilised if records were shared 
between medical and dental service providers.
Participants described the presentation of patients in 
general practice with oral health complaints; this was 
perceived to be due to issues with patients accessing 
dental services, the cost of dental treatment in the UK 
and patients’ phobias of dentists. The healthcare profes-
sional participants reported some knowledge in relation 
to basic oral health advice, however, there is a clear need 
for further education of non- dental health professionals 
to address the limited knowledge of the associated links 
between oral health and systemic diseases.
This is the first study that has explored the role of the 
pharmacist in general practice in relation to the provision 
of oral health advice, but these findings are consistent with 
those in the literature in relation to community pharma-
cists and other healthcare professionals.8 20 There is also a 
need for further interprofessional education between the 
professional groups, as identified our previous qualitative 
studies and in research outside of the UK.35 This could 
act to improve collaboration, reduce the perceived isola-
tion of dental services and optimise patient care.
Pharmacists are now providing more complex clinical 
services in general practice, representing an opportu-
nity to enhance service provision, taking both increased 
responsibility and accountability; this represents an 
opportunity to facilitate the provision of oral health 
advice by this professional group and optimise patient 
care.
Our study has shown that pharmacists in general prac-
tice represent a new avenue for the provision of oral 
healthcare. Further enhancement of this role could 
improve the quality and safety of oral healthcare through 
effective collaboration between pharmacists, other 
members of the primary care health team and the dental 
profession. Professional bodies and the commissioners 
of healthcare services at both a local and national level 
should consider using pharmacists in general practice to 
provide oral health- related advice and/or interventions. 
Further research to explore the potential for this group 
to impact on patient care is needed; however, the integra-
tion of this could potentially have significant benefits for 
patients.
COnCluSIOn
Our findings suggest that clinical pharmacists working 
in general practice are not currently providing optimum 
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care in relation to oral health, with limited incorpora-
tion of oral health issues into current clinical practices. 
However, the disparate contexts of oral and general 
healthcare services, and a lack of clear referral pathways, 
are a significant barrier for the provision of high quality 
and safe oral healthcare in a primary care setting. The 
limited dental input into the multidisciplinary primary 
care team, a lack of communication and the absence of 
access to medical records by relevant primary care health 
professionals are potentially impacting on capacity to 
provide optimal patient care.
Further education in relation to oral health is required 
and could enable improved oral healthcare in this setting; 
the established links between periodontitis and diabetes, 
and the association of specific medicines with oral health- 
related adverse drug reactions represent a key focus for 
pharmacists who are becoming increasingly responsible 
and accountable for patient care in general practice.
The role of the clinical pharmacist working in general 
practice is rapidly developing and growth of this profes-
sional group is part of the NHS General Practice Forward 
View22; this represents an opportunity to integrate oral 
health advice into the management of patients in this 
setting. Further work to explore the benefit and impact 
of providing oral healthcare by this professional group in 
general practice ought to be explored.
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